戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (left1)

通し番号をクリックするとPubMedの該当ページを表示します
1 lone acetonide after explaining the procedure and acquiring consent.
2  to identify ethical and practical challenges of adolescent consent to research participation in these countries.
3 n = 7), death (n = 4), completion of 10 cycles (n = 3), and consent withdrawal (n = 1).
4                                           Given appropriate consent, this could help identify people who are failing to e
5 ble use of anti-parkinsonian medications for 28 days before consent.
6                                     The median time between consent and transplantation of a kidney from an HCV-viremic d
7 rs-of-magnitude to thousands of participants (with explicit consent), enabling advances in vision research, accessibility
8 nics at the primary health-care centres, whose mothers gave consent, were tested by the HemoTypeSC point-of-care test alo
9                            Ideally, individuals should give consent at the time of NGS testing to receive information abo
10 consent requirements, allowing adolescents to independently consent, and implementing surrogate decision making.
11 d, ELSI issues posed by portable neuroimaging: (1) informed consent; (2) privacy; (3) capacity to accurately communicate
12  should use evidence-based practices and a careful informed consent process when choosing intravitreal antibiotics for pa
13  disclosure of genetic information; and a detailed informed consent process.
14 ents less than 72 hours after intubation following informed consent from their next of kin.
15             The study qualified for exception from informed consent (21 Code of Federal Regulations 50.24).
16  standardized questionnaire, and all patients gave informed consent.
17 53 consecutive patients were enrolled after giving informed consent and fulfilling study entry criteria.
18 e asthma exacerbations were recruited after giving informed consent.
19 facilitate donor/recipient matching and to improve informed consent.
20 ow were collected from the patient after obtaining informed consent.
21 tivities do not require further ethical oversight, informed consent, or protections for vulnerable persons or communities
22 inations have important implications for patients' informed consent rights, clinicians' employment rights, and medical ce
23 ide in the area for more than 1 year, and provided informed consent.
24  and research staff safety, infection control, the informed consent model, protocol complexity, data collection, and impl
25  approved this retrospective study, and waived the informed consent requirement.
26 n between 10 and 11 October 2015 following written informed consent.
27  Nov 24, 2011, and June 19, 2014, we recruited and obtained consent from 4096 patients from 97 UK centres, of whom 1361 w
28  research regarding parents' perceived utility, adequacy of consent, and potential harms and benefits is lacking.
29  it prematurely because of loss to follow-up, withdrawal of consent, investigator decision, and an unrelated death from a
30  unacceptable toxicity, loss to follow-up, or withdrawal of consent.
31 ed owing to either poor clinical condition or withdrawal of consent.
32 disease recurrence, unacceptable toxicity, or withdrawal of consent.
33 isease progression, unacceptable toxicity, or withdrawal of consent.
34  lines, (iv) shares data from samples with a similarly open consent to increase the number of samples and populations rep
35 strategies to expand adolescent inclusion: waiving parental consent requirements, allowing adolescents to independently c
36 data were collected from contemporaneous notes, and patient consent was obtained.
37 tment bias was avoided through an ethical waiver to patient consent; a mixture of rural, urban, district, and university
38 from IACS injection and a suggestion for an updated patient consent form are presented.
39 15, nine patients who were referred for transplant provided consent.
40 e is a need to ensure that surgical decision-making and the consent process for this procedure consider these long-term c
41                         Our scoping review identified three consent-related strategies to expand adolescent inclusion: wa
42 f dementia, cardiac or intracranial procedure, inability to consent for themselves, or emergency surgery.
43 than 90% of parents reported feeling adequately informed to consent to diagnostic genomic sequencing.
44 arents in this study perceived being adequately informed to consent, understood their child's results, and denied regret
45 graphic generalizability, exclusion of patients too sick to consent, fluctuations in procedures in the standard arm over
46                    A common theme was the lack of voluntary consent.
47 t of Veterans Affairs (VA), aims to collect biosamples with consent from at least one million veterans.
48 ients, after removal of those who declined or had withdrawn consent, 2463 (95%) were included in the analysis of the prim
49             One participant allocated chemotherapy withdrew consent for data use after randomisation and was excluded fro
50 odified intention-to-treat basis (participants who withdrew consent without contributing a post-randomisation BCVA measur